ALK-Abello (ALKb)

Currency in DKK
239.20
-5.80(-2.37%)
Closed·

ALKb Earnings

Latest Release
Nov 16, 2026
EPS / Forecast
1.60 / 1.70
Revenue / Forecast
1.76B / 1.72B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
12/2026--/0.850--/2.03B----Free Sign Up
09/20261.60/1.701.76B/1.72B-5.88%+2.33%Free Sign Up
06/20261.50/1.601.80B/1.72B-6.25%+4.65%Free Sign Up
03/20262.00/--1.77B/1.70B--+4.12%Free Sign Up
12/20251.20/1.601.73B/1.71B-25%+1.17%Free Sign Up
09/20251.40/1.401.53B/1.47B0%+4.08%Free Sign Up
06/20251.20/1.301.53B/1.51B-7.69%+1.32%Free Sign Up
03/20251.60/--1.52B/------Free Sign Up
12/20240.800/1.031.50B/1.53B-22.33%-1.96%Free Sign Up
09/20241.00/0.7931.31B/1.31B+26.06%0%Free Sign Up

All numbers in DKK

ALK-Abello Earnings Call Summary for Q3/2026

  • ALK reported Q3 2026 revenue of DKK 1.76B, up 15% in local currencies, driven by 35% tablet sales growth; shares fell 4.5% on margin concerns.
  • EBIT margin compressed to 27% from 28% year-over-year as capacity costs rose 20%; management pledged no further cost step-up planned for 2027.
  • Company reaffirmed 2026 guidance of 16-17% revenue growth and 27% EBIT margin; free cash flow expected to exceed DKK 1.1B for the year.
  • ACARIZAX met Phase III trial endpoint in China; filing expected H1 2027 with potential late-2028 launch targeting 100M house dust mite allergy patients.
  • Germany rebate increase effective January 2027 poses profitability risk; neffy launch progressing but remains modest revenue contributor in early stage.
Last Updated: 11/17/2026, 11:32 PM
Read Full Transcript

FAQ

What Is ALK-Abello's Earnings Per Share (TTM)?

The ALK-Abello EPS (TTM) is 6.31.

When Is The Next ALK-Abello Earnings Date?

ALK-Abello will release its next earnings report on Feb 09, 2027.

What Is ALK-Abello’s Revenue Forecasts For Upcoming Quarters?

ALK-Abello’s revenue forecast is 2.03B.

How Did ALK-Abello React to the Company's Latest Earnings Report?

ALK-Abello reported a -5.88% EPS surprise and a +2.33% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -0.97%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.